Eleven Biotherapeutics Company Profile (NASDAQ:EBIO)

About Eleven Biotherapeutics

Eleven Biotherapeutics logoEleven Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye. The Company is conducting research and development programs directed at both diseases of the front of the eye, such as dry eye disease and allergic conjunctivitis, and diseases of the back of the eye, such as diabetic macular edema (DME) and uveitis. The Company's lead product candidate is EBI-005, a cure for dry eye disease and allergic conjunctivitis. Its preclinical product candidates include EBI-031, a cure for DME, and EBI-028, a cure for uveitis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EBIO
  • CUSIP:
Key Metrics:
  • Previous Close: $5.19
  • 50 Day Moving Average: $3.58
  • 200 Day Moving Average: $1.62
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.81
  • P/E Growth: 0.00
  • Market Cap: $79.89M
  • Outstanding Shares: 15,393,000
  • Beta: 3.25
Additional Links:
Companies Related to Eleven Biotherapeutics:

Analyst Ratings

Consensus Ratings for Eleven Biotherapeutics (NASDAQ:EBIO) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Eleven Biotherapeutics (NASDAQ:EBIO)
Show:
DateFirmActionRatingPrice TargetDetails
1/19/2016Citigroup Inc.DowngradeBuy -> NeutralView Rating Details
1/18/2016Leerink SwannDowngradeOutperform -> Market PerformView Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for Eleven Biotherapeutics (NASDAQ:EBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/12/2016Q2($0.33)ViewN/AView Earnings Details
3/24/2016Q4($0.32)($0.53)ViewN/AView Earnings Details
11/4/2015Q315($0.33)($0.50)ViewListenView Earnings Details
8/13/2015Q215($0.43)($0.36)ViewListenView Earnings Details
4/30/2015Q115($0.57)($0.36)ViewListenView Earnings Details
3/4/2015Q414($0.33)($0.49)$375.00 millionViewListenView Earnings Details
11/13/2014Q314($0.44)($0.66)ViewN/AView Earnings Details
8/13/2014($0.47)($0.51)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Eleven Biotherapeutics (NASDAQ:EBIO)
Current Year EPS Consensus Estimate: $-1.75 EPS
Next Year EPS Consensus Estimate: $-1.85 EPS

Dividends

Dividend History for Eleven Biotherapeutics (NASDAQ:EBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Eleven Biotherapeutics (NASDAQ:EBIO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016John J MccabeCFOSell1,170$4.80$5,616.00View SEC Filing  
6/27/2016Abbie CelnikerCEOSell10,029$2.08$20,860.32View SEC Filing  
6/27/2016Karen L TubridyInsiderSell4,372$2.08$9,093.76View SEC Filing  
6/13/2016Boxer Capital, LlcMajor ShareholderSell1,042,000$2.74$2,855,080.00View SEC Filing  
2/16/2016John J MccabeSVPSell1,501$0.27$405.27View SEC Filing  
12/28/2015Abbie CelnikerCEOSell10,155$2.85$28,941.75View SEC Filing  
12/28/2015Eric Steven FurfineInsiderSell4,652$2.85$13,258.20View SEC Filing  
5/8/2015Jafco Super V3 Investment LimiMajor ShareholderSell33,400$13.23$441,882.00View SEC Filing  
2/2/2015Jafco Super V3 Investment LimiMajor ShareholderSell17,900$11.62$207,998.00View SEC Filing  
1/30/2015Jafco Super V3 Investment LimiMajor ShareholderSell120,000$11.62$1,394,400.00View SEC Filing  
1/26/2015Jafco Super V3 Investment LimiMajor ShareholderSell6,300$11.85$74,655.00View SEC Filing  
1/22/2015Jafco Super V3 Investment LimiMajor ShareholderSell6,300$11.82$74,466.00View SEC Filing  
1/16/2015Jafco Super V3 Investment LimiMajor ShareholderSell6,100$12.07$73,627.00View SEC Filing  
8/26/2014Jafco Super V3 Investment LimiMajor ShareholderSell2,000$11.54$23,080.00View SEC Filing  
8/20/2014Jafco Super V3 Investment LimiMajor ShareholderSell1,165$11.54$13,444.10View SEC Filing  
8/18/2014Jafco Super V3 Investment LimiMajor ShareholderSell2,600$11.81$30,706.00View SEC Filing  
8/14/2014Jafco Super V3 Investment LimiMajor ShareholderSell2,000$11.75$23,500.00View SEC Filing  
2/11/2014Jafco Super V3 Investment LimiMajor ShareholderBuy219,790$10.00$2,197,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Eleven Biotherapeutics (NASDAQ:EBIO)
DateHeadline
biz.yahoo.com logoELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Change in Direct (NASDAQ:EBIO)
biz.yahoo.com - August 20 at 8:11 AM
finance.yahoo.com logoELEVEN BIOTHERAPEUTICS, INC. Financials (NASDAQ:EBIO)
finance.yahoo.com - August 19 at 3:51 PM
News IconIntraday Active Biotech Stocks News: Eleven Biotherapeutics, Inc ... - The Voice Registrar (NASDAQ:EBIO)
voiceregistrar.com - August 18 at 10:04 PM
News IconCisco Systems, Inc. (NASDAQ:CSCO) & Eleven Biotherapeutics (NASDAQ:EBIO) Trending Stocks - Money News (press release) (NASDAQ:EBIO)
www.newsismoney.com - August 17 at 10:03 PM
streetinsider.com logoEleven Biotherapeutics (EBIO) Announces Effectiveness of Exclusive IL-6 Tech Licensing Agreement with Roche (NASDAQ:EBIO)
www.streetinsider.com - August 17 at 4:55 PM
investors.com logoEleven Biotherapeutics advances on Roche licensing (NASDAQ:EBIO)
www.proactiveinvestors.com - August 17 at 4:55 PM
4-traders.com logoEleven Biotherapeutics : Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology, Including EBI-031 (NASDAQ:EBIO)
www.4-traders.com - August 17 at 4:55 PM
News IconBlog Coverage Eleven Biotherapeutics Hits Jackpot Grants Hoffmann-La Roche Exclusive Worldwide License (NASDAQ:EBIO)
news.investornetwork.com - August 17 at 4:55 PM
benzinga.com logo20 Stocks Moving In Tuesday's Pre-Market Session - Eleven ... - Benzinga (NASDAQ:EBIO)
www.benzinga.com - August 17 at 7:16 AM
247wallst.com logoCan Eleven Biotherapeutics Keep Climbing With This Roche Deal? (NASDAQ:EBIO)
247wallst.com - August 16 at 4:48 PM
capitalcube.com logoEleven Biotherapeutics, Inc. :EBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (NASDAQ:EBIO)
www.capitalcube.com - August 16 at 4:48 PM
publicnow.com logoEleven Biotherapeutics Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology, Including EBI-031 (NASDAQ:EBIO)
www.publicnow.com - August 16 at 8:00 AM
marketexclusive.com logoMovers and Shakers in Biotech: Global Blood Therapeutics Inc (NASDAQ:GBT) and Eleven Biotherapeutics Inc (NASDAQ:EBIO) (NASDAQ:EBIO)
marketexclusive.com - August 15 at 4:54 PM
insidermonkey.com logoGlobal Blood Therapeutics (NASDAQ:EBIO)
www.insidermonkey.com - August 15 at 4:54 PM
News IconEleven Biotherapeutics Inc (NASDAQ:EBIO): That’s How We Bought At $3.45 And Now Up Huge 65% Already (NASDAQ:EBIO)
www.marketnewscall.com - August 15 at 4:54 PM
biz.yahoo.com logoELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events (NASDAQ:EBIO)
biz.yahoo.com - August 15 at 11:59 AM
News IconStock Earnings Roundup: Eleven Biotherapeutics Inc (NASDAQ:EBIO) - Post Registrar (NASDAQ:EBIO)
postregistrar.com - August 14 at 9:26 AM
finance.yahoo.com logo7:34 am Eleven Biotherapeutics reports Q2 EPS of ($0.33) vs ($0.36) last year; revs $300K versus $100K last year (NASDAQ:EBIO)
finance.yahoo.com - August 12 at 4:47 PM
finance.yahoo.com logo7:34 am Eleven Biotherapeutics reports Q2 EPS of ($0.33) vs ($0.36) last year; revs $300K versus $100K last year (NASDAQ:EBIO)
finance.yahoo.com - August 12 at 4:47 PM
publicnow.com logoEleven Biotherapeutics Reports Second Quarter 2016 Financial Results and Provides Strategic Update (NASDAQ:EBIO)
www.publicnow.com - August 12 at 4:47 PM
publicnow.com logoEleven Biotherapeutics Reports Second Quarter 2016 Financial Results and Provides Strategic Update (NASDAQ:EBIO)
www.publicnow.com - August 12 at 4:47 PM
biz.yahoo.com logoELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:EBIO)
biz.yahoo.com - August 12 at 4:47 PM
biz.yahoo.com logoELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:EBIO)
biz.yahoo.com - August 12 at 4:47 PM
istreetwire.com logoStocks in Focus: Eleven Biotherapeutics, Inc. (EBIO), R.R. Donnelley & Sons Company (RRD), Dollar Tree, Inc. (DLTR) - iStreetWire (NASDAQ:EBIO)
istreetwire.com - August 11 at 7:58 AM
equities.com logoEleven Biotherapeutics Inc. (EBIO) Jumps 8.72% on August 03 - Equities.com (NASDAQ:EBIO)
www.equities.com - August 5 at 8:40 AM
biz.yahoo.com logoELEVEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement (NASDAQ:EBIO)
biz.yahoo.com - August 5 at 8:40 AM
fortune.com logoEleven Biotherapeutics, Inc. (NASDAQ:EBIO): Updated Analyst Ratings - Review Fortune (NASDAQ:EBIO)
reviewfortune.com - August 4 at 10:27 PM
fortune.com logoWhich way Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) insiders ... - Review Fortune (NASDAQ:EBIO)
reviewfortune.com - August 2 at 4:55 PM
streetupdates.com logoInvestors Traded Stocks: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Street Updates (NASDAQ:EBIO)
www.streetupdates.com - August 1 at 4:41 PM
News IconMidnight delivery of Harry Potter book (NASDAQ:EBIO)
learningandfinance.com - July 31 at 9:11 AM
News IconHot Stock seeking Investors: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) - News Oracle (NASDAQ:EBIO)
www.newsoracle.com - July 29 at 4:49 PM
equities.com logoEleven Biotherapeutics Inc. (EBIO) Jumps 10.35% on July 28 - Equities.com (NASDAQ:EBIO)
www.equities.com - July 29 at 4:49 PM
fortune.com logoEleven Biotherapeutics, Inc. (NASDAQ:EBIO) at $4.37: How much higher it can go - Review Fortune (NASDAQ:EBIO)
reviewfortune.com - July 29 at 4:49 PM
nasdaq.com logoEleven Biotherapeutics (EBIO) Jumps: Stock Rises by 10.4% - Nasdaq (NASDAQ:EBIO)
www.nasdaq.com - July 29 at 4:49 PM
News IconStock in Action: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) - News Oracle (NASDAQ:EBIO)
www.newsoracle.com - July 29 at 4:49 PM
4-traders.com logoEleven Biotherapeutics : Four Companies To Consider for Your Portfolio in August 2016 (NASDAQ:EBIO)
www.4-traders.com - July 28 at 9:11 PM
News IconEleven Biotherapeutics Inc (NASDAQ:EBIO): A Top Momentum Pick (NASDAQ:EBIO)
streetregister.com - July 28 at 9:11 PM
equities.com logoEleven Biotherapeutics Inc. (EBIO) Jumps 13.79% on July 27 - Equities.com (NASDAQ:EBIO)
www.equities.com - July 28 at 9:05 AM
equities.com logoEleven Biotherapeutics Inc. (EBIO) Jumps 12.99% on July 26 - Equities.com (NASDAQ:EBIO)
www.equities.com - July 27 at 4:51 PM
nasdaq.com logoEleven Biotherapeutics (EBIO) in Focus: Stock Rises 13% - Nasdaq (NASDAQ:EBIO)
www.nasdaq.com - July 27 at 4:51 PM
fxpips.com logoMarket Recap: Big Moving Stocks – MDGL, CDTI, CCCL, SPHS, SPU, EBIO, THST (NASDAQ:EBIO)
www.fxpips.com - July 27 at 9:28 AM
finance.yahoo.com logoEleven Biotherapeutics (EBIO) in Focus: Stock Rises 13% (NASDAQ:EBIO)
finance.yahoo.com - July 27 at 8:25 AM
News IconEleven Biotherapeutics Inc (NASDAQ:EBIO) Soared Over 30% In Just 3 Hours After Our Call To Subscribers (NASDAQ:EBIO)
www.marketnewscall.com - July 26 at 10:50 PM
streetupdates.com logoSummary of Analysts Rating: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) , Quintiles Transitional Holdings Inc. (NYSE:Q) - Street Updates (NASDAQ:EBIO)
www.streetupdates.com - July 26 at 4:45 PM
fortune.com logoAnalyst Ratings On Watch List: Eleven Biotherapeutics Inc (NASDAQ:EBIO), Oclaro, Inc. (NASDAQ:OCLR) - Review Fortune (NASDAQ:EBIO)
reviewfortune.com - July 26 at 4:45 PM
equities.com logoEleven Biotherapeutics Inc. (EBIO) Jumps 14.5% on July 25 - Equities.com (NASDAQ:EBIO)
www.equities.com - July 26 at 8:32 AM
streetupdates.com logoStocks Movements to Focus: Abbott Laboratories (NYSE:ABT) , Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) - Street Updates (NASDAQ:EBIO)
www.streetupdates.com - July 21 at 4:54 PM
News IconStock Performance to Track: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) - News Oracle (NASDAQ:EBIO)
www.newsoracle.com - July 21 at 4:54 PM
News IconCould Eleven Biotherapeutics Inc See a Reversal After This Very Strong Session? - Consumer Eagle (NASDAQ:EBIO)
www.consumereagle.com - July 21 at 8:12 AM
equities.com logoEleven Biotherapeutics Inc. (EBIO) Jumps 8.13% on July 20 - Equities.com (NASDAQ:EBIO)
www.equities.com - July 21 at 8:12 AM

Social

Eleven Biotherapeutics (NASDAQ:EBIO) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff